why choose us

First received: February 15, 2023

Clinical Trial: EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Lipid Disorder

Study Type: INTERVENTIONAL


Official Title: EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)

Brief Summary: The EMERALD intervention involves 1) ordering an Emergency Department (ED) lipid panel, 2) calculating 10-year Atherosclerotic cardiovascular disease (ASCVD) risk using the Pooled Cohort Equations, 3) prescribing a moderate- or high-intensity statin if applicable, and 4) referring patients to outpatient care (primary care, preventive cardiology, or general cardiology, depending on risk level).

Read more